Previous studies have shown that both convalescent COVID-19 patients and individuals vaccinated with any of the different COVID-19 vaccine platforms develop long-term immunity mediated by CD4+ and CD8+ specific T cells [11]. The gene discussed is CD8A; the disease is COVID-19.